EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q2 Statement of Cash Flows

Income StatementCash FlowBalance Sheet

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
EDWARDS LIFESCIENCES CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Calculated remaining financing cash flows are purple; remaining operating and investing bundles are gray. Their underlying inflows and outflows are not separately identified. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net income → Net cash from operating activities: $241,400,000.00Deferred income taxes → Operating adjustments reconciliation: $181,300,000.00Accounts payable and accrued liabilities → Operating adjustments reconciliation: $123,700,000.00Depreciation and amortization → Operating adjustments reconciliation: $42,700,000.00Stock-based compensation (Note 10) → Operating adjustments reconciliation: $42,200,000.00Loss on impairment (Note 6) → Operating adjustments reconciliation: $40,000,000.00Prepaid expenses and other current assets → Operating adjustments reconciliation: $29,500,000.00Income taxes → Operating adjustments reconciliation: $12,000,000.00Non-cash operating lease cost → Operating adjustments reconciliation: $6,600,000.00Other → Operating adjustments reconciliation: $400,000.00Operating adjustments reconciliation → Net cash from operating activities: $410,500,000.00Operating adjustments reconciliation → Inventories: $23,500,000.00Operating adjustments reconciliation → Gain on remeasurement of previously held interest upon business combinations (Note 7): $19,900,000.00Operating adjustments reconciliation → Other: $10,800,000.00Operating adjustments reconciliation → Accounts and other receivables, net: $10,200,000.00Operating adjustments reconciliation → Remaining operating cash flows, net (calculated): $3,500,000.00Proceeds from available-for-sale investments (Note 5) → investing reconciliation: $442,600,000.00Proceeds from held-to-maturity investments (Note 5) → investing reconciliation: $5,900,000.00Issuances of notes receivable → investing reconciliation: $2,000,000.00Business combinations, net of cash (Note 7) → investing reconciliation: $1,400,000.00investing reconciliation → Purchases of available-for-sale investments (Note 5): $558,300,000.00investing reconciliation → Capital expenditures: $66,900,000.00investing reconciliation → Investments in unconsolidated affiliates: $7,100,000.00investing reconciliation → Other: $7,000,000.00investing reconciliation → Purchases of held-to-maturity investments (Note 5): $5,800,000.00Net cash used in financing activities → financing reconciliation: $300,000.00Equity forward contract related to accelerated share repurchase agreement (Note 11) → financing reconciliation: $100,000,000.00Proceeds from stock plans → financing reconciliation: $53,800,000.00financing reconciliation → Purchases of treasury stock: $153,300,000.00financing reconciliation → Other: $800,000.00Net cash used in investing activities → investing reconciliation: $193,200,000.00Exchange-rate effect → Cash sources and uses: $3,800,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $2,447,500,000.00Net cash from operating activities → Cash sources and uses: $651,900,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $2,909,700,000.00Cash sources and uses → Net cash used in investing activities: $193,200,000.00Cash sources and uses → Net cash used in financing activities: $300,000.00Net income: $241,400,000.00Net income+$241.40 MDepreciation and amortization: $42,700,000.00Depreciation & amortization+$42.70 MNon-cash operating lease cost: $6,600,000.00Operating lease amortization+$6.60 MStock-based compensation (Note 10): $42,200,000.00Stock-based compensation+$42.20 MDeferred income taxes: $181,300,000.00Deferred tax balances+$181.30 MGain on remeasurement of previously held interest upon business combinations (Note 7): -$19,900,000.00Stake remeasurement gain & loss−$19.90 MLoss on impairment (Note 6): $40,000,000.00Asset impairments+$40.00 MOther: -$10,800,000.00Other non-cash items−$10.80 MAccounts and other receivables, net: -$10,200,000.00Accounts & other receivables−$10.20 MInventories: -$23,500,000.00Inventories−$23.50 MAccounts payable and accrued liabilities: $123,700,000.00Payables & accrued liabilities+$123.70 MIncome taxes: $12,000,000.00Income taxes payable+$12.00 MPrepaid expenses and other current assets: $29,500,000.00Prepaid & other assets+$29.50 MIntellectual property agreement accrual: $0.00Other: $400,000.00Other working capital, net+$400.00 KRemaining operating cash flows, net (calculated): -$3,500,000.00Remaining operating (calculated)−$3.50 MNet cash from operating activities: $651,900,000.00Operating cash+$651.90 MOperating adjustments reconciliation: $478,400,000.00Purchases of treasury stock: -$153,300,000.00Common stock repurchases−$153.30 MEquity forward contract related to accelerated share repurchase agreement (Note 11): $100,000,000.00Accelerated repurchase forward+$100.00 MProceeds from stock plans: $53,800,000.00Stock plan proceeds+$53.80 MOther: -$800,000.00Other financing, net−$800.00 KNet cash used in financing activities: -$300,000.00. Cash required to fund net payments.Financing cash−$300.00 Kfinancing reconciliation: $154,100,000.00Capital expenditures: -$66,900,000.00PP&E purchases−$66.90 MInvestments in unconsolidated affiliates: -$7,100,000.00Investments in affiliates−$7.10 MPurchases of held-to-maturity investments (Note 5): -$5,800,000.00HTM securities purchases−$5.80 MProceeds from held-to-maturity investments (Note 5): $5,900,000.00HTM sales & maturities+$5.90 MPurchases of available-for-sale investments (Note 5): -$558,300,000.00AFS securities purchases−$558.30 MProceeds from available-for-sale investments (Note 5): $442,600,000.00AFS securities proceeds+$442.60 MPayment for working capital adjustment for sale of product group (Note 4): $0.00Business combinations, net of cash (Note 7): $1,400,000.00Acquisitions, net of cash+$1.40 MPayment for acquisition options: $0.00Issuances of notes receivable: $2,000,000.00Issuances of notes receivable+$2.00 MOther: -$7,000,000.00Other investing, net−$7.00 MNet cash used in investing activities: -$193,200,000.00. Cash required to fund net payments.Investing cash−$193.20 Minvesting reconciliation: $645,100,000.00Cash sources and uses: $3,103,200,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $2,447,500,000.00Beginning cash$2.45 BEnding cash: Cash, cash equivalents, and restricted cash: $2,909,700,000.00Ending cash$2.91 BExchange-rate effect: $3,800,000.00FX effect+$3.80 MCASH RECONCILIATIONOperatingflowsInvestingflowsFinancingflowsFree cash flow$585.00 MOperating cash − cash spent on PP&ECash flow / Net income2.70×Operating cash flow ÷ net incomeNet cash change+$462.20 MEnding cash − beginning cash
Chart details

EDWARDS LIFESCIENCES CORPORATION cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
2,447,500,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
651,900,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Loss on investments, net), so those amounts cannot be separated for this quarter. It may combine inflows and outflows.
Net income
241,400,000 US dollars
Depreciation and amortization
42,700,000 US dollars
Non-cash operating lease cost
6,600,000 US dollars
Stock-based compensation (Note 10)
42,200,000 US dollars
Deferred income taxes
181,300,000 US dollars
Gain on remeasurement of previously held interest upon business combinations (Note 7)
negative 19,900,000 US dollars
Loss on impairment (Note 6)
40,000,000 US dollars
Other
negative 10,800,000 US dollars
Accounts and other receivables, net
negative 10,200,000 US dollars
Inventories
negative 23,500,000 US dollars
Accounts payable and accrued liabilities
123,700,000 US dollars
Income taxes
12,000,000 US dollars
Prepaid expenses and other current assets
29,500,000 US dollars
Intellectual property agreement accrual
0 US dollars
Other
400,000 US dollars
Remaining operating cash flows, net (calculated)
negative 3,500,000 US dollars
Investing activities
negative 193,200,000 US dollars. Net cash used.
Capital expenditures
negative 66,900,000 US dollars
Investments in unconsolidated affiliates
negative 7,100,000 US dollars
Purchases of held-to-maturity investments (Note 5)
negative 5,800,000 US dollars
Proceeds from held-to-maturity investments (Note 5)
5,900,000 US dollars
Purchases of available-for-sale investments (Note 5)
negative 558,300,000 US dollars
Proceeds from available-for-sale investments (Note 5)
442,600,000 US dollars
Payment for working capital adjustment for sale of product group (Note 4)
0 US dollars
Business combinations, net of cash (Note 7)
1,400,000 US dollars
Payment for acquisition options
0 US dollars
Issuances of notes receivable
2,000,000 US dollars
Other
negative 7,000,000 US dollars
Financing activities
negative 300,000 US dollars. Net cash used.
Purchases of treasury stock
negative 153,300,000 US dollars
Equity forward contract related to accelerated share repurchase agreement (Note 11)
100,000,000 US dollars
Proceeds from stock plans
53,800,000 US dollars
Other
negative 800,000 US dollars
Operating adjustment reconciliation
478,400,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
financing gross reconciliation
154,100,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
645,100,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
3,800,000 US dollars
Ending cash on Jun 30, 2026
2,909,700,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
3,103,200,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
462,200,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
2.70×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
651,900,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
66,900,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
585,000,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $410.50M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 651,900,000 US dollars minus 66,900,000 US dollars equals 585,000,000 US dollars.
EDWARDS LIFESCIENCES CORPORATION (EW) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!